Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients

J Nephrol. 2022 Apr;35(3):761-763. doi: 10.1007/s40620-021-01235-3. Epub 2022 Jan 17.
No abstract available

Keywords: Booster; COVID-19; End stage renal disease; Hemodialysis; Kidney transplantation; Peritoneal dialysis; Vaccines; Viral infections.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't